Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

Research Square logoLink to Research Square
[Preprint]. 2026 Jan 27:rs.3.rs-8663578. [Version 1] doi: 10.21203/rs.3.rs-8663578/v1

Process Safety Assessment of the Iron-Catalyzed 1,2-cis-Selective Glycal Aminoglycosylation

Dakang Zhang 1, Nicola Colombo 1, Zixiang Jiang 1, Davide Pirola 1, Marino Nebuloni 1, Hao Xu 1
PMCID: PMC12892158  PMID: 41684750

Abstract

Complex glycans are directly involved in numerous disease processes and their structural motifs are increasingly incorporated in pharmaceuticals and biological probes. Therefore, the development highly stereoselective and broadly effective glycosylation processes that are safe and readily scalable has been of great value in both academia and industry. We report herein a process safety assessment of an iron-catalyzed, entirely 1,2-cis-selective glycosylation process for the synthesis of a broad range of biologically important 1,2-cis-aminoglycosides. Differential Scanning Calorimetry analysis of the corresponding catalyst, amination reagents, and an array of representative 1,2-cis-aminoglycosides revealed that all of them are thermal stable at temperatures at least 200°C above the glycosylation temperature. Drop Weight Test of the amination reagents suggested that they are impact-stable. Guided by this assessment, we have developed a multigram-scale synthesis of stereochemically pure Tn antigen via the iron-catalyzed 1,2-cis-selective glycal aminoglycosylation.

Keywords: Iron; Catalysis; Glycosylation; Process Safety Assessment; 1,2-cis-Aminoglycoside

Introduction

Complex carbohydrates are directly involved in numerous physiological and disease processes, so their structural motifs are increasingly incorporated in pharmaceuticals and biological probes (Figure 1).1–4 Over the past century, many powerful chemical glycosylation methods have been invented,5–9 but one major hurdle still remains: the stereoselectivity in glycosylation often varies with substrates, so it is difficult to develop a highly stereoselective glycosylation method that is also broadly effective. In particular, there is no general solution for highly 1,2-cis-selective glycosylation.10

1,2-cis-2-Amino glycosidic linkages are present in many pharmaceuticals and biologically important complex glycans, including anticoagulant heparan sulfate11–12 and Fondaparinux1, aminoglycoside antibiotics, and O-linked glycopeptides. Unlike 1,2-trans-2-amino glycosides which can be prepared by established methods,13–20 it is still challenging to reliably form 1,2-cis-2-amino glycosidic linkages in high stereoselectivity. The existing cis-selective methods leverage non-neighboring-participating groups, particularly the azido group, to enhance the 1,2-cis-selectivity (Figure 2A);21–31 however, these methods are most effective for certain types of substrates with specific substituents or conformations. Structural variations in either glycosyl donors or glycosyl acceptors often compromise the high 1,2-cis-selectivity. In addition, organic azides may present potential safety concerns for their handling, which adds to the difficulty for process development of large-scale 1,2-cis-selective aminoglycosylation.

Inspired by our research program of the iron-catalyzed selective nitrogen atom transfer for olefin functoinalization,32–34 we envisioned a unique approach that would lead to exclusively 1,2-cis-selective aminoglycosylation (Figure 2B). We hypothesized that an iron catalyst could activate a glycosyl acceptor and an amination reagent, and subsequently transfer both moieties to a glycal that is otherwise unreactive in the absence of the catalyst. As both the nitrogen atom transfer step and the glycosyl-acceptor transfer step would be directed by the iron catalyst, we predict that the amido group and the catalyst-activated glycosyl acceptor could be cooperatively delivered to a glycal in an exclusively cis-selective manner. Distinct from existing glycosylation methods, the unactivated glycosyl acceptor is unlikely to compete for the same reactive intermediate, which should minimize or even eliminate stereochemical erosion from the non-stereoselective pathways.

Directly building upon a pair of iron-catalyzed olefin aminohydroxylation reactions discovered in our lab in 201332 and 201433 (Figure 3A), we have recently developed an iron-catalyzed 1,2-cis-selective glycal aminoglycosylation method (Figure B).35 A readily available iron catalyst–Fe(L1)(BF4)2(MeCN)(H2O)2 136, is uniquely effective in promoting the exclusively 1,2-cis-selective aminoglycosylation between a bench-stable glycal, a glycosyl acceptor, and an amination reagent (Figure 3B). Catalyst 1 facilitates facile cleavage of the N-O bond of acyloxy carbamate 2 and transfers both the carbamate fragment of 2 and the glycosyl acceptor to the glycal in an exclusively cis-selective manner from the a-face, affording the desired aminoglycoside (dr >20:1). This 1,2-cis-selective method is effective for a broad range of glycosyl donors and acceptors (Figure 4). Additionally, it plays a pivotal role in highly stereoselective synthesis of biologically important Tn antigens37–39 and heparan sulfate oligosaccharides40 (Figure 3B).

The iron catalyst 1 capitalizes on the high energy N–O bond in acyloxy carbamate 2 to drive the glycosylation under cryogenic conditions (−40 °C); however, it is known that thermal hazards could be present in molecules with weak N–O bonds,41 which may present potential safety concerns for their handling, with regard to their thermo- and mechanical impact stabilities. In order to explore the feasibility of this iron-catalyzed glycosylation on an industrial scale, it is imperative to carry out chemical hazard assessment of this reaction. A reactive chemical hazard assessment refers the identification and possibly quantification of dangerous energy release scenarios for a chemical process of interest. Herein, we describe our chemical safety studies and potential hazard assessment of the iron-catalyzed 1,2-cis-selective glycosylation, using Differential Scanning Calorimetry (DSC) and Drop Weight Test (DWT) analysis.

Results and Discussion

We selected the iron-catalyzed glycosylation of primary and secondary acceptors (4 and 6) with glycal 3 and amination reagents 2a/2b as the model reactions for safety analysis. Kinetic studies of the glycosylation of primary acceptor 4 with electron-rich glycal 3 and amination reagent 2a (Eq. 1 in Scheme 1) suggested that its initial rate has a first-order dependence on the iron catalyst, an inverse first-order dependence on acceptor 4, and a zero-order dependence on both amination reagent 2a and glycal 3.35 Kinetic studies further revealed that the initial rate for glycosylation of secondary acceptor 6 with amination reagent 2b and glycal 3 (Eq. 2 in Scheme 1) has a first-order dependence on the iron catalyst but a zero-order dependence on each of acceptor 6, glycal 3, and amination reagent 2b.35

As our first step to explore the feasibility of applying this reaction on an industrial scale, we conducted a series of thermal stability tests using Differential Scanning Calorimetry (DSC) (Fig. 5, Fig. 6, Fig. 7, and Figure S13).

We first evaluated the thermal stability of amination reagents 2a and 2b as they contain high energy N–O bonds and are used in super-stoichiometric amounts in the glycosylation. The DSC experiment concluded that amination reagent 2a melts at 77°C and starts to decompose at 122°C (Tonset: 154°C, ΔH: −637 J/g) (Fig. 5). A second exothermic event was observed starting around 188°C (Tonset: 190°C, ΔH: −354 J/g), which is likely due to decomposition of the 2-bromoisobutyric acid moiety in 2a. Amination reagent 2b, derived from 2-acetoxyisobutyric acid, melts at 62°C and shows only one exothermic event (Tonset: 172°C, ΔH: −610 J/g) in the thermogram (Fig. 5). Notably, the decomposition onset temperatures of both 2a and 2b are significantly higher than the glycosylation temperature (− 40°C), providing a safety operating temperature margin (> 200°C) for large-scale operation.

The N-Boc group is known to undergo spontaneous decarboxylation at elevated temperatures;42 therefore, we next evaluated the thermal stability of the corresponding N-Troc–protected amination reagents 2d and 2e (Fig. 5). Notably, 2d and 2e are much less-efficient for the glycal 1,2-cis-aminoglycosylation which provides low conversions and low yields.35 Surprisingly, both 2d and 2e exhibited markedly broader exothermic events in their DSC thermograms, spanning more than 130°C, which were accompanied by substantially larger enthalpies of decomposition (ΔH: −1232 and − 1782 J/g, respectively). These distinct thermal profiles suggested that the N-Boc-protected acyloxy carbamates (2a and 2b) are thermally more stable than their N-Troc-protected analogs and that the presence of multiple halogen atoms may contribute to their decreased thermal stability.

Our kinetic studies of this glycosylation suggested that its initial rate has a first-order dependence on iron catalyst 1, so we further evaluated the catalyst’s thermal stability. We observed that iron catalyst 1 is thermally stable and there is no exothermic event up to 143°C in an isochoric setting (Tonset: 153°C, ΔH: −293 J/g, Fig. 6). Interestingly, two endothermic events were observed in an isobaric setting (Tonset: 137°C and ΔH: 196 J/g, Tonset: 179°C and ΔH: 128 J/g), presumably due to the decomposition of 1 with the development of gaseous products. Once again, the decomposition onset temperature of 1 is much higher than the catalytic glycosylation temperature, which offers a comfortable temperature margin for safe large-scale operation.

Based upon these DSC results, we subsequently evaluated the mechanic impact sensitivities of iron catalyst 1 and amination reagents (2a and 2b) by the Fall Hammer Test (Drop Weight Test). Gratifyingly, all of them uniformly demonstrate negative results in the DWT. These data confirm higher stability of the product under any mechanical impact during the process product manipulation.

To assure that the 1,2-cis-aminoglycosylation products are amenable to large-scale production, we also carried out the DSC analysis of two 1,2-cis-aminoglycosides (5 and 7) that were used in kinetic studies (Fig. 7). Aminoglycoside 5 melts at 156°C, yet its DSC thermogram displays a couple of mild endothermic and exothermic events up to 198°C (ΔH: up to − 24 J/g), presumably due to solid-solid transition. We observed a significant thermal decomposition starting at 215°C (Tonset: 252°C, ΔH: −110 J/g). Interestingly, aminoglycoside 7 displays only an exothermic event at a higher temperature in the DSC analysis (Tonset: 240°C, ΔH: −145 J/g). These results suggested that the 1,2-cis-aminoglycosylation products are thermally stable for handling at room temperature. Furthermore, we carried out the DSC experiments for several other synthetically valuable aminoglycosides with distinct steric and electronic properties, including 8, 9, and 10 and concluded that they are all thermal stable (Fig. 7).

We further explored potential runaway scenarios in which one or more components were inadvertently omitted from the iron-catalyzed glycosylation (Scheme 2). We observed that omission of a glycosyl acceptor resulted in formation of a 1,2-cis-glycal aminoacyloxylation product 11. In DSC analysis of 11, only a single exothermic event was observed (Tonset = 190°C, ΔH: −256 J/g, Fig. 7). In the absence of a glycal donor, regardless the presence of a glycosyl acceptor 4, amination reagent 2a was partially decomposed to BocNH2 (12) and 2-bromoisobutyric acid (13) with low conversion (< 20% conversion). DSC analysis of 12 revealed two endothermic events (Tonset = 88°C, ΔH = 22 J/g; Tonset = 228°C, ΔH = 230 J/g), in addition to its melting at 108°C (Figure S13). Collectively, these results suggested that the iron-catalyzed glycal 1,2-cis-aminoglycosylation does not exhibit hazardous exothermic behavior under plausible reagent-omission scenarios and that this glycosylation is amenable to large-scale operation.

The observed thermal stability of 1,2-cis-amido galactosyl serine benzyl ester 10 (Tn antigen) is particularly encouraging, as it is a key building block for O-linked glycopeptide synthesis. The synthesis of stereochemically pure Tn antigens is critically important for the access to homogeneous O-linked glycopeptides. However, this has been challenging because the embedded 1,2-cis-amidoglycosidic linkage is difficult to form reliably in high stereoselectivity. The vast majority of existing syntheses of Tn antigens leverage non-neighboring participating groups, most notably the azido group, to enhance the cis-selectivity.10, 21–25, 30, 43–54 However, structural variations either in galactosyl donors or amino acid acceptors often compromise the high 1,2-cis-selectivity, affording diastereomeric mixtures.21, 29, 51–64 Based upon this process safety assessment, we developed a 10 mmol scale, iron-catalyzed 1,2-cis-aminoglycosylation procedure for the synthesis of fully protected Tn antigen (10). The commercially available and bench-stable tri-O-acetyl-D-galactal (14) and N-Cbz serine benzyl ester (15) are readily glycosylated by iron catalyst 1 and amination reagent 2a, affording protected Tn antigen 10 in high yield (Scheme 3, 6.09 g, 85% yield). Rapid and scalable postglycosylation deprotection procedures minimize aqueous workups and readily afford single diastereomeric Tn antigen (16).37

Conclusions

In conclusion, we have carried out process safety assessment of the iron-catalyzed glycal 1,2-cis-aminoglycosylation process through Differential Scanning Calorimetry and Drop Weight Test of the corresponding iron catalyst, reagents, and representative glycosylation products. These experiments suggest that all of them are thermal stable at temperatures at least 200°C above the glycosylation temperature and that the amination reagents are impact-stable. Guided by these process safety studies, we have developed a multigram-scale, iron-catalyzed glycosylation process that readily affords stereochemically pure Tn antigen.

Experimental Section

Differential Scanning Calorimetry (DSC).

The DSC measurements were performed in a Mettler Toledo DSC1 using 40 μL aluminum punctured crucibles under nitrogen atmosphere or 75 μL medium pressure Perkin Elmer stinless steel crucibles under air atmosphere. All measurements were carried out at a heating rate of 5 K/min.

Mechanical Sensitivity Test.

The Fall Hammer Test (Drop Weight Test) was designed to determine the sensitivity of potentially high explosive compounds and it was carried out by dropping a 7 Kg-weight from the height of 0.5 m in accordance to the UN Recommendation on the Transport of Dangerous Goods, Manual of Tests and Criteria–Test 3 (a) (ii) as well as EN 13631–4.

A Procedure for the Large-Scale Iron-Catalyzed Glycal 1,2-cis-Aminoglycosylation of 15 with 14 and 2a.

To a flame-dried 100 mL round bottom flask (flask A) equipped with a stir bar were added tri-O-acetyl-D-galactal (14) (2.72 g, 10 mmol, 1.0 equiv), N-Cbz serine benzyl ester (15) (4.61 g, 14 mmol, 1.4 equiv), iron catalyst Fe(L1)(BF4)2(MeCN)(H2O)2 (1) (580 mg, 1 mmol, 10 mol %), and freshly activated 5 Å powdered molecular sieves (ca. 4 g). After the flask was evacuated and backfilled with N2 twice, anhydrous CH2Cl2 (8 mL) and freshly opened 1,4-dioxane (2 mL) were added and the flask was cooled to − 78°C. To a flame-dried 25 mL round bottom flask (flask B) was added acyloxyl carbamate 2a (4.23 g, 15 mmol, 1.5 equiv). Flask B was evacuated and backfilled with N2 twice and anhydrous CH2Cl2 (10 mL) was added. Then the solution in flask B was transferred to flask A via a syringe in 10 min. The reaction was kept at − 78°C for an additional 3 min before switched to − 40°C. The reaction was kept at − 40°C for 4 h and quenched by precipitating the iron catalyst with Et2O (40 mL) at the same temperature. The mixture was stirred for two minutes and subsequently warmed up to room temperature. The solution was then filtered through a short pad of Celite® and washed with saturated aq. NaHCO3 solution (15 mL). The organic phase was separated from the aqueous one, which was further extracted with CH2Cl2 (15 mL × 3). The combined organic phase was dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column (hexanes/acetone: from 20:1 to 5:1) to afford the desired product 10 as white foam (6.09 g, 85% yield).

Supplementary Material

Experimental procedure, characterization data for all new compounds and selected NMR spectra. The Supporting Information is available free of charge on the ACS Publications website.

Schemes 1 to 3 are available in the Supplementary Files section.

ACKNOWLEDGMENT

This research was supported by the National Institutes of Health (GM134926). We thank NIH Shared Instrumentation grant S10OD034395 (NMR) for the instrument support.

Footnotes

Additional Declarations: The authors declare no competing interests.

Data Availability Statement

All data generated or analyzed during this study are included in this published article and its Supporting Information file.

References

  • 1.Petitou M, van Boeckel CAA, Synthetic Antithrombin A (2004) Binding Pentasaccharide Is Now a Drug! What Comes Next? Angew Chem Int Ed 43:3118–3133 [DOI] [PubMed] [Google Scholar]
  • 2.Becker B, Cooper MA (2013) Aminoglycoside Antibiotics in the 21st Century. ACS Chem Biol 8:105–115 [DOI] [PubMed] [Google Scholar]
  • 3.Danishefsky SJ, Shue Y-K, Chang MN, Wong C-H (2015) Development of Globo-H Cancer Vaccine. Acc Chem Res 48:643–652 [DOI] [PubMed] [Google Scholar]
  • 4.Ruck RT, Shekhar S (2025) The Value of Industrial Editors at ACS Catalysis: A Personal Perspective. ACS Catal 13727–13730 [Google Scholar]
  • 5.Danishefsky SJ, Bilodeau MT (1996) Glycals in Organic Synthesis: The Evolution of Comprehensive Strategies for the Assembly of Oligosaccharides and Glycoconjugates of Biological Consequence. Angew Chem Int Ed 35:1380–1419 [Google Scholar]
  • 6.Boltje TJ, Buskas T, Boons G-J (2009) Opportunities and Challenges in Synthetic Oligosaccharide and Glycoconjugate Research. Nat Chem 1:611–622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zhu X, Schmidt RR (2009) New Principles for Glycoside-Bond Formation. Angew Chem Int Ed 48:1900–1934 [DOI] [PubMed] [Google Scholar]
  • 8.Yu B (2018) Gold(I)-Catalyzed Glycosylation with Glycosyl o-Alkynylbenzoates as Donors. Acc Chem Res 51:507–516 [DOI] [PubMed] [Google Scholar]
  • 9.Levi SM, Jacobsen EN (2019) Catalyst-Controlled Glycosylation. In Org. React., John Wiley & Sons, Inc.: ; Vol. 100, pp 801–852 [Google Scholar]
  • 10.Nigudkar SS, Demchenko AV (2015) Stereocontrolled 1,2-cis Glycosylation as the Driving Force of Progress in Synthetic Carbohydrate Chemistry. Chem Sci 6:2687–2704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Damus PS, Hicks M, Rosenberg RD (1973) Anticoagulant Action of Heparin. Nature 246:355–357 [DOI] [PubMed] [Google Scholar]
  • 12.Liu J, Thorp SC (2002) Cell Surface Heparan Sulfate and Its Roles in Assisting Viral Infections. Med Res Rev 22:1–25 [DOI] [PubMed] [Google Scholar]
  • 13.Griffith DA, Danishefsky SJ (1990) Sulfonamidoglycosylation of Glycals. A Route to Oligosaccharides with 2-Aminohexose Subunits. J Am Chem Soc 112:5811–5819 [Google Scholar]
  • 14.Fitzsimmons BJ, Leblanc Y, Rokach J (1987) [4 + 2] Cycloaddition of Azodicarboxylate and Glycals: a Novel and Simple Method for the Preparation of 2-Amino-2-Deoxy Carbohydrates. J Am Chem Soc 109:285–286 [Google Scholar]
  • 15.Du Bois J, Tomooka CS, Hong J, Carreira EM (1997) Novel, Stereoselective Synthesis of 2-Amino Saccharides. J Am Chem Soc 119:3179–3180 [Google Scholar]
  • 16.Di Bussolo V, Liu J, Huffman JLG, Gin DY (2000) Acetamidoglycosylation with Glycal Donors: A One-Pot Glycosidic Coupling with Direct Installation of the Natural C(2)-N-Acetylamino Functionality. Angew Chem Int Ed 39:204–207 [DOI] [PubMed] [Google Scholar]
  • 17.Kan C, Long CM, Paul M, Ring CM, Tully SE, Rojas CM (2001) Photo Amidoglycosylation of an Allal Azidoformate. Synthesis of β-2-Amido Allopyranosides. Org Lett 3:381–384 [DOI] [PubMed] [Google Scholar]
  • 18.Gege C, Oscarson S, Schmidt RR (2001) Synthesis of Fluorescence Labeled Sialyl LewisX Glycosphingolipids. Tetrahedron Lett 42:377–380 [Google Scholar]
  • 19.Shang W, Zhu C, Peng F, Pan Z, Ding Y, Xia C (2021) Nitrogen-Centered Radical-Mediated Cascade Amidoglycosylation of Glycals. Org Lett 23:1222–1227 [DOI] [PubMed] [Google Scholar]
  • 20.Xu Y, Montgomery J (2024) Synthesis of 2-Amino-2-deoxy Sugars via Boron-Catalyzed Coupling of Glycosyl Fluorides and Silyl Ether Acceptors. Org Lett 26:7474–7478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Winterfeld GA, Schmidt RR, Concatenation N (2001) A Broadly Applicable and Efficient Approach to the Synthesis of Complex O-Glycans. Angew Chem Int Ed 40:2654–2657 [DOI] [PubMed] [Google Scholar]
  • 22.Benakli K, Zha C, Kerns RJ (2001) Oxazolidinone Protected 2-Amino-2-deoxy-D-glucose Derivatives as Versatile Intermediates in Stereoselective Oligosaccharide Synthesis and the Formation of a-Linked Glycosides. J Am Chem Soc 123:9461–9462 [DOI] [PubMed] [Google Scholar]
  • 23.Orgueira HA, Bartolozzi A, Schell P, Seeberger PH (2002) Conformational Locking of the Glycosyl Acceptor for Stereocontrol in the Key Step in the Synthesis of Heparin. Angew Chem Int Ed 41:2128–2131 [PubMed] [Google Scholar]
  • 24.Manabe S, Ishii K, Ito Y (2006) N-Benzyl-2,3-oxazolidinone as a Glycosyl Donor for Selective α-Glycosylation and One-Pot Oligosaccharide Synthesis Involving 1,2-cis-Glycosylation. J Am Chem Soc 128:10666–10667 [DOI] [PubMed] [Google Scholar]
  • 25.Park J, Kawatkar S, Kim J-H, Boons G-J (2007) Stereoselective Glycosylations of 2-Azido-2-deoxy-glucosides Using Intermediate Sulfonium Ions. Org Lett 9:1959–1962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mensah EA, Nguyen HM (2009) Nickel-Catalyzed Stereoselective Formation of a-2-Deoxy-2-Amino Glycosides. J Am Chem Soc 131:8778–8780 [DOI] [PubMed] [Google Scholar]
  • 27.Mensah EA, Yu F, Nguyen HM (2010) Nickel-Catalyzed Stereoselective Glycosylation with C(2)-N-Substituted Benzylidene D-Glucosamine and Galactosamine Trichloroacetimidates for the Formation of 1,2-cis-2-Amino Glycosides. Applications to the Synthesis of Heparin Disaccharides, GPI Anchor Pseudodisaccharides, and α-GalNAc. J Am Chem Soc 132:14288–14302 [DOI] [PubMed] [Google Scholar]
  • 28.Yoshida K, Yang B, Yang W, Zhang Z, Zhang J, Huang X (2014) Chemical Synthesis of Syndecan-3 Glycopeptides Bearing Two Heparan Sulfate Glycan Chains. Angew Chem Int Ed 53:9051–9058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Medina S, Harper MJ, Balmond EI, Miranda S, Crisenza GEM, Coe DM, McGarrigle EM, Galan MC (2016) Stereoselective Glycosylation of 2-Nitrogalactals Catalyzed by a Bifunctional Organocatalyst. Org Lett 18:4222–4225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Codeé JDC, Wang L, Zhang Y, Overkleeft HS, van der Marel GA (2020) Reagent Controlled Glycosylations for the Assembly of Well-Defined Pel Oligosaccharides. J Org Chem 85:15872–15884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhang Y, Ma X, Zhang L (2023) Highly Stereoselective Synthesis of 2-Azido-2-Deoxyglycosides via Gold-Catalyzed SN2 Glycosylation. CCS Chem 5:2799–2807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liu G-S, Zhang Y-Q, Yuan Y-A, Xu H (2013) Iron(II)-Catalyzed Intramolecular Aminohydroxylation of Olefins with Functionalized Hydroxylamines. J Am Chem Soc 135:3343–3346 [DOI] [PubMed] [Google Scholar]
  • 33.Lu D-F, Zhu C-L, Jia Z-X, Xu H (2014) Iron(II)-Catalyzed Intermolecular Amino-Oxygenation of Olefins through the N–O Bond Cleavage of Functionalized Hydroxylamines. J Am Chem Soc 136:13186–13189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Tian J-S, Zhu C-L, Chen Y-R, Xu H (2015) Iron-Catalyzed Diastereoselective Intramolecular Olefin Aminobromination with Bromide Ion. Synthesis 47:1709–1715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Li H, Zhang D, Li C, Yin L, Jiang Z, Luo Y, Xu H (2024) Stereoselective Glycosylation for 1,2-cis-Aminoglycoside Assembly by Cooperative Atom Transfer Catalysis. J Am Chem Soc 146:33316–33323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lu D-F, Zhu C-L, Sears JD, Xu H (2016) Iron(II)-Catalyzed Intermolecular Aminofluorination of Unfunctionalized Olefins Using Fluoride Ion. J Am Chem Soc 138:11360–11367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yin L, Zhang D, Jiang Z, Xu H (2025) Stereoselective Multigram-Scale Tn Antigen Synthesis via the Iron-Catalyzed Glycal 1,2-cis-Aminoglycosylation. Org Lett 27:5515–5520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zhang X-W, Yin L, Zhang D, Jiang Z, Wang P, Xu H (2025) Iron-Catalyzed Highly Stereospecific Glycosylation with Glycal Epoxides. Angew Chem Int Ed 64:e202517634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jiang Z, Zhang D, Wang P, Yin L, Xu H (2025) Iron-Catalyzed Stereoselective Glycosylation for 1,2-cis-Aminoglycoside Assembly. Nat Protoc. 10.1038/s41596-025-01263-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Zhang D, Jiang Z, Yin L, Zhang X-W, Yang H, Wang P, Xie C, Stancanelli E, Xu Y, Wang H, Sun J, Liu J, Xu H (2026) Merging Enzymatic Catalysis with Iron Catalysis for Highly Stereoselective Heparan Sulfate Oligosaccharide Assembly. J Am Chem Soc 148:1766–1778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Topczewski JJ, Cheek H, Gruber JM, Marsh BM, Valco DJ (2025) Thermal Hazard Evaluation and Safety Considerations for the Use of O-Benzoyl-N-alkyl Hydroxylamines as Synthetic Reagents. Org Process Res Dev 29:2497–2503 [Google Scholar]
  • 42.Ryan M-R, Lynch D, Collins SG, Maguire AR (2024) Selective Thermal Deprotection of N-Boc Protected Amines in Continuous Flow. Org Process Res Dev 28:1946–1963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mensah EA, Nguyen HM (2009) Nickel-Catalyzed Stereoselective Formation of α-2-Deoxy-2-Amino Glycosides. J Am Chem Soc 131:8778–8780 [DOI] [PubMed] [Google Scholar]
  • 44.Kaifu R, Osawa T (1977) Synthesis of O-(2-acetamido-2-. Carbohydr Res 58:235–239. deoxy-α-D-galactopyranosyl)-N-tosyl-L-serine [DOI] [PubMed] [Google Scholar]
  • 45.Ratcliffe RM, Baker DA, Lemieux RU (1981) Synthesis of the T [b-D-Gal-(1→3)-a-D-GalNAc]-antigenic Determinant in a Form Useful for the Preparation of an Effective Artificial Antigen and the Corresponding Immunoadsorbent. Carbohydr Res 93:35–41 [DOI] [PubMed] [Google Scholar]
  • 46.Kunz H, Birnbach S (1986) Synthesis of O-Glycopeptides of the Tumor-Associated Tn- and T-Antigen Type and Their Binding to Bovine Serum Albumin. Angew Chem Int Ed 25:360–362 [Google Scholar]
  • 47.Svarovsky SA, Barchi JJ (2003) Highly Efficient Preparation of Tumor Antigen-Containing Glycopeptide Building Blocks from Novel Pentenyl Glycosides. Carbohydr Res 338:1925–1935 [DOI] [PubMed] [Google Scholar]
  • 48.Ryan DA, Gin DY (2008) Ring-Opening of Aziridine-2-Carboxamides with Carbohydrate C1-O-Nucleophiles. Stereoselective Preparation of a- and b-O-Glycosyl Serine Conjugates. J Am Chem Soc 130:15228–15229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wang S, Chen C, Gadi MR, Saikam V, Liu D, Zhu H, Bollag R, Liu K, Chen X, Wang F, Wang PG, Ling P, Guan W, Li L (2021) Chemoenzymatic Modular Assembly of O-GalNAc Glycans for Functional Glycomics. Nat Commun 12:3573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cato D, Buskas T, Boons GJ (2005) Highly Efficient Stereospecific Preparation of Tn and TF Building Blocks Using Thioglycosyl Donors and the Ph2SO/Tf2O Promotor System. J Carbohydr Chem 24:503–516 [Google Scholar]
  • 51.Chen X-T, Sames D, Danishefsky SJ (1998) Exploration of Modalities in Building a-O-Linked Systems through Glycal Assembly: A Total Synthesis of the Mucin-Related F1a Antigen. J Am Chem Soc 120:7760–7769 [Google Scholar]
  • 52.Yu F, McConnell MS, Nguyen HM (2015) Scalable Synthesis of Fmoc-Protected GalNAc-Threonine Amino Acid and TN Antigen via Nickel Catalysis. Org Lett 17:2018–2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Shou K, Zhang Y, Ji Y, Liu B, Zhou Q, Tan Q, Li F, Wang X, Lu G, Xiao G (2024) Highly Stereoselective a-Glycosylation with GalN3 Donors Enabled Collective Synthesis of Mucin-Related Tumor Associated Carbohydrate Antigens. Chem Sci 15:6552–6561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Xu Z, Deng Y, Zhang Z, Ma W, Li W, Wen L, Li T (2021) Diversity-Oriented Chemoenzymatic Synthesis of Sulfated and Nonsulfated Core 2 O-GalNAc Glycans. J Org Chem 86:10819–10828 [DOI] [PubMed] [Google Scholar]
  • 55.Kerns RJ, Zha CX, Benakli K, Liang YZ (2003) Extended Applications and Potential Limitations of Ring-Fused 2,3-Oxazolidinone Thioglycosides in Glycoconjugate Synthesis. Tetrahedron Lett 44:8069–8072 [Google Scholar]
  • 56.Shaik AA, Nishat S, Andreana PR (2015) Stereoselective Synthesis of Natural and Non-natural Thomsen-nouveau Antigens and Hydrazide Derivatives. Org Lett 17:2582–2585 [DOI] [PubMed] [Google Scholar]
  • 57.Kunz H, Birnbach S, Wernig P (1990) Synthesis of Glycopeptides with the Tn and T Antigen Structures, and Their Coupling to Bovine Serum Albumin. Carbohydr Res 202:207–223 [DOI] [PubMed] [Google Scholar]
  • 58.Koeller KM, Smith MEB, Wong C-H (2000) Chemoenzymatic Synthesis of PSGL-1 Glycopeptides: Sulfation on Tyrosine Affects Glycosyltransferase-Catalyzed Synthesis of the O-Glycan. Bioorg Med Chem 8:1017–1025 [DOI] [PubMed] [Google Scholar]
  • 59.Kuduk SD, Schwarz JB, Chen X-T, Glunz PW, Sames D, Ragupathi G, Livingston PO, Danishefsky SJ (1998) Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer. J Am Chem Soc 120:12474–12485 [Google Scholar]
  • 60.Elofsson M, Salvador A, Kihlberg L (1997) Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120. Tetrahedron 53:369–390 [Google Scholar]
  • 61.Elofsson M, Salvador A, Kihlberg L (1997) Preparation of Tn and Sialyl Tn Building Blocks Used in Fmoc Solid-Phase Synthesis of Glycopeptide Fragments from HIV gp120. Tetrahedron 53:369–390 [Google Scholar]
  • 62.Nakahara Y, Iijima H, Sibayama S, Ogawa T (1990) A Highly Stereoselective Synthesis of Di- and Trimeric Sialosyltn Epitope: A Partial Structure of Glycophorin A. Tetrahedron Lett 31:6897–6900 [Google Scholar]
  • 63.Winterfeld GA, Ito Y, Ogawa T, Schmidt RR, Novel A (1999) and Efficient Route towards a-GalNAc-Ser and a-GalNAc-Thr Building Blocks for Glycopeptide Synthesis. Eur. J. Org. Chem. 1999, 1167–1171 [Google Scholar]
  • 64.Zhang M, Gan J, Peng P, Li T (2025) Stereoselective Synthesis of 1,2-cis-O-Linked Glycosyl Amino Acids via Additive-Modulation for Glycopeptide Synthesis. Chem Eur J e202404786. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article and its Supporting Information file.


Articles from Research Square are provided here courtesy of American Journal Experts

RESOURCES